After five straight years of rapid expansion, India’s biotechnology industry slowed to 20% growth in the year to March, down from more than 30% in the previous years, largely due to a rising rupee and price pressures in the global market. The industry earned Rs10,273 crore, up from Rs8,541 crore in the fiscal year that ended in March 2007, according to an annual biotech industry survey conducted by industry body Association of Biotech Led Enterprises (ABLE) and trade journal BioSpectrum.